{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T01:25:02Z","timestamp":1791509102217,"version":"4.3.4"},"reference-count":30,"publisher":"European Respiratory Society (ERS)","issue":"1","license":[{"start":{"date-parts":[[2020,4,7]],"date-time":"2020-04-07T00:00:00Z","timestamp":1586217600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.ersjournals.com\/user-licence"}],"funder":[{"DOI":"10.13039\/100005564","name":"Gilead Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005564","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["publications.ersnet.org"],"crossmark-restriction":true},"short-container-title":["Eur Respir J"],"accepted":{"date-parts":[[2020,3,31]]},"published-print":{"date-parts":[[2020,7]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Inhaled antibiotics may improve symptom scores, but it is not known which specific symptoms improve with therapy. Item-level analysis of questionnaire data may allow us to identify which specific symptoms respond best to treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      <jats:italic>Post hoc<\/jats:italic>\n                      analysis of the AIR-BX1 studies and two trials of inhaled aztreonam\n                      <jats:italic>versus<\/jats:italic>\n                      placebo in bronchiectasis. Individual items from the quality of life bronchiectasis (QOL-B) respiratory symptom scale, were extracted as representing severity of nine distinct symptoms. Generalised linear models were used to evaluate changes in symptoms with treatment\n                      <jats:italic>versus<\/jats:italic>\n                      placebo from baseline to end of first on-treatment cycle and mixed models were used to evaluate changes across the full 16-week trial.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Aztreonam improved cough (difference 0.22, 95% CI 0.08\u20130.37; p=0.002), sputum production (0.30, 95% CI 0.15\u20130.44; p&lt;0.0001) and sputum colour (0.29, 95% CI 0.15\u20130.43; p&lt;0.0001)\n                      <jats:italic>versus<\/jats:italic>\n                      placebo equating to a 20% improvement in cough and 25% improvement in sputum production and colour. Similar results were observed for cough, sputum production and sputum purulence across the trial duration (all p&lt;0.05). Patients with higher sputum production and sputum colour scores had a greater response on the overall QOL-B (difference 4.82, 95% CI 1.12\u20138.53; p=0.011 for sputum production and 5.02, 95% CI 1.19\u20138.86; p=0.01 for sputum colour). In contrast, treating patients who had lower levels of bronchitic symptoms resulted in shorter time to next exacerbation (hazard ratio 1.83, 95% CI 1.02\u20133.28; p=0.042).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Baseline bronchitic symptoms predict response to inhaled aztreonam in bronchiectasis. More sensitive tools to measure bronchitic symptoms may be useful to better identify inhaled antibiotic responders and to evaluate patient response to treatment.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1183\/13993003.00608-2020","type":"journal-article","created":{"date-parts":[[2020,4,7]],"date-time":"2020-04-07T17:54:10Z","timestamp":1586282050000},"page":"2000608","update-policy":"https:\/\/doi.org\/10.1183\/ers-crossmark-policy","source":"Crossref","is-referenced-by-count":36,"title":["Inhaled aztreonam improves symptoms of cough and sputum production in patients with bronchiectasis: a\n                    <i>post hoc<\/i>\n                    analysis of the AIR-BX studies"],"prefix":"10.1183","volume":"56","author":[{"given":"Megan L.","family":"Crichton","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mike","family":"Lonergan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan F.","family":"Barker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oriol","family":"Sibila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pieter","family":"Goeminne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7360-6060","authenticated-orcid":false,"given":"Amelia","family":"Shoemark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James D.","family":"Chalmers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"81","published-online":{"date-parts":[[2020,4,7]]},"reference":[{"key":"2024102101323338000_56.1.2000608.1","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00629-2017"},{"key":"2024102101323338000_56.1.2000608.2","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/s12890-018-0631-7","article-title":"\u201cThe missing ingredient\u201d: the patient perspective of health related quality of life in bronchiectasis: a qualitative study","volume":"18","author":"Dudgeon","year":"2018","journal-title":"BMC Pulm Med"},{"key":"2024102101323338000_56.1.2000608.3","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00051-2017"},{"key":"2024102101323338000_56.1.2000608.4","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2018-212463"},{"key":"2024102101323338000_56.1.2000608.5","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01888-2015"},{"key":"2024102101323338000_56.1.2000608.6","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2016-208481"},{"key":"2024102101323338000_56.1.2000608.7","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01953-2017"},{"key":"2024102101323338000_56.1.2000608.8","doi-asserted-by":"publisher","DOI":"10.1513\/AnnalsATS.201506-333OC"},{"key":"2024102101323338000_56.1.2000608.9","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/S2213-2600(19)30185-7","article-title":"The efficacy and safety of inhaled antibiotics for the treatment of bronchiectasis in adults: a systematic review and meta-analysis","volume":"7","author":"Laska","year":"2019","journal-title":"Lancet Respir Med"},{"key":"2024102101323338000_56.1.2000608.10","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1016\/j.chest.2017.04.167","article-title":"Pharmacotherapy for non-cystic fibrosis bronchiectasis: results from an NTM Info & Research patient survey and the Bronchiectasis and NTM Research Registry","volume":"152","author":"Henkle","year":"2017","journal-title":"Chest"},{"key":"2024102101323338000_56.1.2000608.11","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2014-205918"},{"key":"2024102101323338000_56.1.2000608.12","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00303-2019"},{"key":"2024102101323338000_56.1.2000608.13","doi-asserted-by":"publisher","DOI":"10.1165\/ajrcmb.26.4.4473"},{"key":"2024102101323338000_56.1.2000608.14","doi-asserted-by":"publisher","DOI":"10.1165\/ajrcmb\/4.1.26"},{"key":"2024102101323338000_56.1.2000608.15","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201203-0487OC"},{"key":"2024102101323338000_56.1.2000608.16","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1016\/j.chest.2017.11.033","article-title":"The BRICS (Bronchiectasis Radiologically Indexed CT Score): a multicenter study score for use in idiopathic and postinfective bronchiectasis","volume":"153","author":"Bedi","year":"2018","journal-title":"Chest"},{"key":"2024102101323338000_56.1.2000608.17","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/S2213-2600(14)70165-1","article-title":"Aztreonam for inhalation solution in patients with non-cystic fibrosis bronchiectasis (AIR-BX1 and AIR-BX2): two randomised double-blind, placebo-controlled phase 3 trials","volume":"2","author":"Barker","year":"2014","journal-title":"Lancet Respir Med"},{"key":"2024102101323338000_56.1.2000608.18","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1164\/rccm.201809-1651OC","article-title":"Airway bacterial load and inhaled antibiotic response in bronchiectasis","volume":"200","author":"Sibila","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"key":"2024102101323338000_56.1.2000608.19","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S2213-2600(18)30427-2","article-title":"Inhaled liposomal ciprofloxacin in patients with non-cystic fibrosis bronchiectasis and chronic lung infection with Pseudomonas aeruginosa (ORBIT-3 and ORBIT-4): two phase 3, randomised controlled trials","volume":"7","author":"Haworth","year":"2019","journal-title":"Lancet Respir Med"},{"key":"2024102101323338000_56.1.2000608.20","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.02053-2017"},{"key":"2024102101323338000_56.1.2000608.21","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.02052-2017"},{"key":"2024102101323338000_56.1.2000608.22","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.02444-2017"},{"key":"2024102101323338000_56.1.2000608.23","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/resp.12219","article-title":"The Sputum Colour Chart as a predictor of lung inflammation, proteolysis and damage in non-cystic fibrosis bronchiectasis: a case-control analysis","volume":"19","author":"Goeminne","year":"2014","journal-title":"Respirology"},{"key":"2024102101323338000_56.1.2000608.24","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201605-1027OC"},{"key":"2024102101323338000_56.1.2000608.25","doi-asserted-by":"publisher","DOI":"10.1136\/thorax.56.5.366"},{"key":"2024102101323338000_56.1.2000608.26","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.164.9.2105083"},{"key":"2024102101323338000_56.1.2000608.27","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1164\/rccm.201906-1219OC","article-title":"Airway mucus hyperconcentration in non-cystic fibrosis bronchiectasis","volume":"201","author":"Ramsey","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"2024102101323338000_56.1.2000608.28","doi-asserted-by":"publisher","DOI":"10.1378\/chest.117.5_suppl_1.317S"},{"key":"2024102101323338000_56.1.2000608.29","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1164\/rccm.201812-2351OC","article-title":"Pregnancy zone protein is associated with airway infection, neutrophil extracellular trap formation, and disease severity in bronchiectasis","volume":"200","author":"Finch","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"key":"2024102101323338000_56.1.2000608.30","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1164\/rccm.201507-1449LE","article-title":"Aerosolized antibiotics for patients with bronchiectasis","volume":"193","author":"Nadig","year":"2016","journal-title":"Am J Respir Crit Care Med"}],"container-title":["European Respiratory Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1183\/13993003.00608-2020","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T02:31:53Z","timestamp":1740364313000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.ersnet.org\/lookup\/doi\/10.1183\/13993003.00608-2020"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,7]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,7,16]]},"published-print":{"date-parts":[[2020,7]]}},"alternative-id":["10.1183\/13993003.00608-2020"],"URL":"https:\/\/doi.org\/10.1183\/13993003.00608-2020","relation":{},"ISSN":["0903-1936","1399-3003"],"issn-type":[{"value":"0903-1936","type":"print"},{"value":"1399-3003","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,7]]}}}